Kim, S.; Choi, I.; Han, I.-H.; Bae, H.
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. Int. J. Mol. Sci. 2022, 23, 15751.
https://doi.org/10.3390/ijms232415751
AMA Style
Kim S, Choi I, Han I-H, Bae H.
Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. International Journal of Molecular Sciences. 2022; 23(24):15751.
https://doi.org/10.3390/ijms232415751
Chicago/Turabian Style
Kim, Soyoung, Ilseob Choi, Ik-Hwan Han, and Hyunsu Bae.
2022. "Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer" International Journal of Molecular Sciences 23, no. 24: 15751.
https://doi.org/10.3390/ijms232415751
APA Style
Kim, S., Choi, I., Han, I. -H., & Bae, H.
(2022). Enhanced Therapeutic Effect of Optimized Melittin-dKLA, a Peptide Agent Targeting M2-like Tumor-Associated Macrophages in Triple-Negative Breast Cancer. International Journal of Molecular Sciences, 23(24), 15751.
https://doi.org/10.3390/ijms232415751